Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema
Clinical trial NCT05083689 · UNKNOWN
Trial details
- NCT number
- NCT05083689
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2022-03-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.